57-41-0 5,5-Diphenylhydantoin

Name: 5,5-Diphenylhydantoin
Synonyms: Hydantoin,5,5-diphenyl- (8CI);5,5-Diphenyl-1H-imidazolidine-2,4-dione;5,5-Diphenyl-2,4-imidazolidinedione;Aleviatin;DPH;Di-Lan;Dilabid;Dintoina;Diphantoin;Diphedan;Diphenat;Diphenylan;Ekko;Hidantal;Hydantol;Lehydan;NSC 8722;Phenytoin;Phenytoine;Sodanton;Zentropil;
CAS Number:57-41-0
Molecular Formula:C₁₅H₁₂N₂O₂
Molecular Weight:252.29
EINECS:200-328-6
Density:1.257g/cm³
Boiling Point:°Cat760mmHg
Flash Point:°C
Safety Description:Confirmed carcinogen producing lymphoma, Hodgkin's disease, tumors of the skin and appendages. Experimental carcinogenic and tumorigenic data. A human poison by ingestion. Poison experimentally by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Moderately toxic by an unspecified route. Experimental teratogenic and reproductive effects. Human systemic effects by ingestion: dermatitis, change in motor activity (specific assay), ataxia (loss of muscle coordination), degenerative brain changes, encephalitis, hallucinations, distorted perceptions, irritability, and jaundice. Human teratogenic effects by ingestion: developmental abnormalities of the central nervous system, cardiovascular (circulatory) system, musculoskeletal system, craniofacial area, skin and skin appendages, eye, ear, other developmental abnormalities. Effects on newborn include abnormal growth statistics (e.g., reduced weight gain), physical abnormalities, other postnatal measures or effects, and delayed effects. Human mutation data reported. A drug for the treatment of grand mal and psychomotor seizures. When heated to decomposition it emits toxic fumes of NO_x.
liansport Information: